Document is current
Any future updates will be listed below
-
Authors
Vogel, Annette B.
Lui, Bonny G.
Tompkins, Kristin
Kanevsky, Isis
Muik, Alexander
Krumm, Stefanie A.
Güler, Alptekin
Maddur, Mohan S.
Walzer, Kerstin C.
Witzel, Sonja
Vascotto, Fulvia
Stanganello, Eliana
Ota-Setlik, Ayuko
Cottingham, Kimberly J.
Allbritton, Omaira
Keverne, Jessica
Aragão-Santiago, Letícia
Swanson, Kena A.
Türeci, Özlem
Şahin, Uğur
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 28 December 2025
First Online: 13 January 2026
Competing interests
: The authors declare that U.S. and Ö.T. are management board members and employees at BioNTech SE (Mainz, Germany); A.B.V., B.G.L., A.M., S.A.K., A.G., K.C.W., S.W., L.A-S., Ö.T., and U.S. are employees at BioNTech SE and may hold securities from BioNTech SE. K.T., I.K., K.J.C., O.A., and K.A.S. are current employees at Pfizer (Pearl River, NY) and may hold securities from Pfizer. M.S.M. and A.O.S. were previously employed by Pfizer. JK was previously employed by BioNTech SE. A.B.V., A.M., A.G., K.C.W., S.W., Ö.T., and U.S. are inventors on patents and patent applications related to RNA technology and COVID-19 vaccines.
